Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AirGOs ASA desensitization trial in AERD
2017-001570-42Phase 4Terminated
- Sponsor
- Helsinki University Hospital
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (AERD), chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma comparing Aspirin desensitization with Placebo (2 arms). Primary endpoints: Change in nasal endoscopic polyp score, Change in SNOT-22 and 1 more. Started Apr 2018; status: terminated.
02
Drugs
aspirin
03
Conditions
nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (AERD)chronic rhinosinusitis with nasal polyps (CRSwNP)asthma
Beyond the preview
Go deeper on 2017-001570-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001570-42.